Clopidogrel resistance caused by a failure to metabolize clopidogrel into its metabolites
- 1 May 2006
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (5) , 1143-1145
- https://doi.org/10.1111/j.1538-7836.2006.01891.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Proinflammatory Cytokines, Markers of Cardiovascular Risks, Oxidative Stress, and Lipid Peroxidation in Patients With Hyperglycemic CrisesDiabetes, 2004
- Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial InfarctionCirculation, 2004
- Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel ResistanceCirculation, 2004
- Pharmacokinetics of clopidogrel after administration of a high loading doseThrombosis and Haemostasis, 2004
- Adenosine Diphosphate–Induced Platelet Aggregation Is Associated With
P2Y
12
Gene Sequence Variations in Healthy SubjectsCirculation, 2003
- Clopidogrel for Coronary StentingCirculation, 2003
- Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet AggregationCirculation, 2003
- Down‐regulation of human CYP3A4 by the inflammatory signal interleukin 6: molecular mechanism and transcription factors involvedThe FASEB Journal, 2002
- Identification and Biological Activity of the Active Metabolite of ClopidogrelThrombosis and Haemostasis, 2000